Old drug, new hope: can a repurposed HIV medication fix anemia in bone marrow cancer?
NCT ID NCT07281781
Summary
This study is testing if Nelfinavir, a drug originally used for HIV, can help treat anemia in people with myelofibrosis, a rare bone marrow cancer. Researchers want to see if the drug helps restore iron to the bone marrow to improve red blood cell counts and reduce scarring. The trial will enroll about 10 adults with myelofibrosis and low hemoglobin.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOFIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Chao Family Comprehensive Cancer Center, University of California, Irvine
RECRUITINGOrange, California, 92868, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.